07:30 EST Abbott (ABT) to acquire Exact Sciences (EXAS) for $105 per share, or equity value ~$21B
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT:
- Abbott Laboratories’ Strategic Acquisition of Exact Sciences Drives Buy Rating
- Mizuho says $100 per share takeout price for Exact Sciences ‘feasible’
- Abbott Laboratories’ Strategic Acquisition of Exact Sciences: A Catalyst for Diagnostics Growth and Market Expansion
- BofA moves to No Rating on Exact Sciences after Abbott report
- Strategic Acquisition and Growth Prospects Drive Buy Rating for Abbott Laboratories